ZA200109700B - Modular cell carrier systems for the three-dimensional cell growth. - Google Patents
Modular cell carrier systems for the three-dimensional cell growth. Download PDFInfo
- Publication number
- ZA200109700B ZA200109700B ZA200109700A ZA200109700A ZA200109700B ZA 200109700 B ZA200109700 B ZA 200109700B ZA 200109700 A ZA200109700 A ZA 200109700A ZA 200109700 A ZA200109700 A ZA 200109700A ZA 200109700 B ZA200109700 B ZA 200109700B
- Authority
- ZA
- South Africa
- Prior art keywords
- cell
- segments
- cells
- cell support
- dimensional
- Prior art date
Links
- 230000010261 cell growth Effects 0.000 title description 12
- 210000004027 cell Anatomy 0.000 claims description 132
- 239000011148 porous material Substances 0.000 claims description 28
- 239000012528 membrane Substances 0.000 claims description 13
- 125000006850 spacer group Chemical group 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 3
- 210000000130 stem cell Anatomy 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 description 25
- 239000010410 layer Substances 0.000 description 22
- 238000000034 method Methods 0.000 description 22
- 235000015097 nutrients Nutrition 0.000 description 22
- 238000004113 cell culture Methods 0.000 description 11
- 230000001413 cellular effect Effects 0.000 description 11
- 230000008901 benefit Effects 0.000 description 9
- 230000004069 differentiation Effects 0.000 description 9
- 238000009826 distribution Methods 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 210000000056 organ Anatomy 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 241000264877 Hippospongia communis Species 0.000 description 6
- 230000004087 circulation Effects 0.000 description 6
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 5
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 5
- 210000002744 extracellular matrix Anatomy 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 238000010276 construction Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000005538 encapsulation Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 210000003292 kidney cell Anatomy 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 4
- -1 poly(methyl methacrylate) Polymers 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000013459 approach Methods 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000012832 cell culture technique Methods 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 210000003494 hepatocyte Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000010412 perfusion Effects 0.000 description 3
- 238000012958 reprocessing Methods 0.000 description 3
- 238000012876 topography Methods 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- 230000036770 blood supply Effects 0.000 description 2
- 210000003321 cartilage cell Anatomy 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- 208000007788 Acute Liver Failure Diseases 0.000 description 1
- 206010000804 Acute hepatic failure Diseases 0.000 description 1
- 239000000592 Artificial Cell Substances 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000043299 Parathyroid hormone-related Human genes 0.000 description 1
- 101710123753 Parathyroid hormone-related protein Proteins 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 238000001015 X-ray lithography Methods 0.000 description 1
- 231100000836 acute liver failure Toxicity 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000008614 cellular interaction Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001312 dry etching Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000009713 electroplating Methods 0.000 description 1
- 238000004049 embossing Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000012606 in vitro cell culture Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000008776 intercellular pathway Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 108010082117 matrigel Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- 210000000885 nephron Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000001020 plasma etching Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000002763 pyramidal cell Anatomy 0.000 description 1
- 238000010107 reaction injection moulding Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000013337 sub-cultivation Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- ZBZJXHCVGLJWFG-UHFFFAOYSA-N trichloromethyl(.) Chemical compound Cl[C](Cl)Cl ZBZJXHCVGLJWFG-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000000264 venule Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/10—Hollow fibers or tubes
Landscapes
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Sustainable Development (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Description
: , : 0.2. 5444 - 1 -
CREAVIS Gesellschaft fiir Technologie und Innovation mbH
PATENT MARKEN
Modular cell support systems for three-dimensional cell growth
The present invention relates to artificial cell support systems for three-dimensional cell growth and the use thereof.
The cultivation of animal, human and, increasingly, also plant cells is now employed for a large number of tasks. These include not only scientific purposes and pharmacological investigations but also, increasingly, biotechnological applications such as the production of antibodies and pharmaceuticals. All these applications are based on a two-dimensional growth habit of the cells because only one cell layer (monolayer) can be cultivated with most cell culture techniques.
During serial subcultivation of cells or primary cultures there is often found to be a change in gene expression. This also applies to many immortalized cell lines, which often show only a fraction remaining of their original differentiation. Besides genetic instability, there are other reasons for this differentiation in vitro. The cells in the natural tissue assemblage (in vivo) grow in an environment which is spatially highly structured. This results in different cell interactions and consequently an entirely different cellular activity and proliferation.
Another very important feature of the natural tissue assemblage is vascularization. This comprises a dense network of blood vessels (capillaries and venules) which ensure that the cells are supplied with growth factors and oxygen.
This realization has led to refined cell culture techniques which are based more closely on the natural
' ’ - 0.2. 5444 - 2 - environment (in vivo) and include the extracellular matrix (ECM) in the in vitro system.
In vitro cell cultures often grow only two- dimensionally (monolayers) . Multilayer growth is desired not only to construct thicker layers but also in order to obtain a cell assemblage capable of functioning, such as, for example, an organ. Cell assemblages not only have a high cell density but also show interactions between the cells or other tissues.
These interactions are epigenetic factors necessary for cellular proliferation and differentiation.
This is why increased efforts have been made recently also to produce multilayer cell cultures (multilayers).
The first approaches to this use a three-dimensional growth framework on which the cells can proliferate.
The form taken by such frameworks varies very widely. A technique which is now often used is to produce an extracellular matrix from laminin, Matrigel, fibronetin and collagen (e.g.: E.A. Blomme et al., “Influence of extracellular matrix macromolecules on normal human keratinocyte phenotype and parathyroid hormone-related protein secretion and expression in vitro” in
Experimental Cell Research, (1998), 238; 1; 204-15). In this technique, the culture vessels are coated with a more or less thin layer of these components. The structure produced in this way 1s then used as framework for growing various cell types.
Other approaches make use of cellulose foams or hydrogels as frameworks for growing cell cultures, as described in EP 0 451 707-A. The advantage of these foams is the very good surface/volume ratio, i.e. for a small volume a very large surface is provided as adhesion area for cell growth. These growth matrices are often also coated with an extracellular matrix in order to ensure better proliferation and differentiation (see, for example: Y. Watanabe et al., “TNF-alpha bifunctionally induces proliferation in
) a . . o - 0.Z. 5444 - 3 - primary hepatocytes: role of cell anchorage and spreading” in Journal of Immunology; (1997), pp. 4840-7). Examples of materials employed to produce such foam-like cell supports are cellulose derivatives.
The pore formation in these foams is important, because the cells settle in the pores or else nutrients are supplied through small pores in the material. However, only inadequate control of the dimensions of the pores is possible. If the pores are too small, no cells can grow therein, and if the pores are too large unwanted two-dimensional cell growth takes place there. The supply of nutrients which is crucial for growth of the cells, and the transport away of metabolic products likewise depends on a defined pore size distribution.
The difficulty of controlling the pore size distribution thus results in the controllability of cell growth being inadequate.
To date it has not been possible to cultivate any functional tissue or organ assemblages using these ideas. These techniques have failed when used for purposes requiring a greater degree of differentiation and thicker cell layers such as, for example, connective tissue or artificial organs. One reason for this is that the supply of thick cell layers with nutrient media and oxygen, as is ensured in vivo by vascularization of the tissue, cannot be guaranteed.
Supplying the cells with oxygen and nutrients by intercellular pathways is possible only through a few cells or cell layers.
The use of semipermeable membranes has partly remedied this. A system which makes use of polymer fabrics as support system in conjunction with a perfusion chamber is described, for example, by M. Sittinger et al. in “The International Journal of Artificial Organs” 1997, vol. 20, No. 1, pp. 57-62. In this case, cartilages are cultivated in the first step to give a maximally confluent monolayer on large areas of fabric. The cells a | AMENDED SHEET > 0.2. 5444 - 4 - @ are then introduced into a perfusion culture system.
Cartilage cells are able to grow well in these chambers because an exchange of nutrients and waste products which is adequate for this type of tissue is ensured therein. However, the limits of this technique are reached after only a few layers of cells, so that tissue types which require intensive supplying with nutrients and oxygen cannot be cultivated using this technique.
It is likewise possible to produce an approximately three-dimensional structure by suitably layering individual membranes one on top of the other. The disadvantage of this structure is, however, that it is not self-supporting and can be stacked poorly or only up to a small height, and the nutrient supply through the lengths of membrane on top of one another is difficult to control.
In addition, the individual cell layers are not in mutual contact and thus take the form of two- dimensional layers stacked one on top of the other, and not a three-dimensional structure.
J.C. Hager et al. describe in J. Natl. Cancer Inst., 69, 6 (1982) 1359-66, a System of ordered bundles of hollow fibers for cultivating tumor cells. These fibers serve as surface for cell adhesion and, through pores in the fibers, as supply pathway for providing nutrients and oxygen. It is possible with them to achieve three-dimensional cell growth. Ordered cell growth is not possible owing to the difficulty of controlling the distances between fibers. In addition, the length, diameter and arrangement of the fibers determine the extent and structure of the tissue to be cultivated.
WO 90/02796 and US 5 510 254 describe another possibility for constructing approximately three- dimensional cell structures. In this case, mesh-like cell support structures, coated where appropriate with
AMENDED SHEET
- 0.Z. 5444 - 5 - -@ growth-promoting substances, are employed. The tissues can be arranged to give sSuperstructures, in which case a cellular connection between the individual layers depends on the distance between them and thus can likewise be influenced only inadequately. Systems of this type are suitable for cell structures with a few layers, but a complex multilayer three-dimensional cell structure cannot be cultivated using these tissues.
Further developments of cell Support systems are described in E. Wintermantel, S.-W. Ha, *“Biokompatible
Werkstoffe und Bauweisen~” Springer Verlag 1996,
Pp. 98-109. There is discussion here in particular of the surface topography and surface functionality of porous supports. However, these Support systems likewise do not have defined pore sizes or surface characteristics adapted to the cell type employed and/or the desired burpose of use. Deliberate three- dimensional construction of cellular tissues is not possible using these techniques.
A need exists to provide a cell support with which three-dimensional cellular tissues can be cultivated in vitro and in vivo.
It has been found that it is also possible to produce complex three-dimensional cellular tissues using a cel} support system consisting of modularly formed segments of a porous material.
The present invention therefore relates to a cell support system of porous material, where the cell support system consists of modularly formed segments which are wholly or partly constructed from half shells.
The porosity of the modularly formed segments can be adapted specifically to suit the cell type used. The modularly formed segments may have, depending on the
: 0.z2. 5444 - 6 - cell type, pores with an average diameter of from 0.5 to 5 um. The distribution of the pores is advantageously chosen so that between one and three pores are available per grown cell for supplying the cells, i.e. the average distance between the pores in the segments is advantageously from 1 to 10 um. The segments of the cell supports have wholly or partly a porous structure, the target being cell growth preferably only at the porous points in the segments.
The nonporous points in the segments can, owing to the reduced cell growth there, be employed for attachment purposes or the like.
The cellular tissue cultivated on the cell support systems according to the invention is, because of the excellent vascularization, capable of proliferation in vitro and in vivo. The modular form of the segments makes it possible to construct cell support systems of virtually any shape and complexity. The optional connection between two or more segments makes it possible to cultivate coherent cell and tissue cultures of virtually any size.
Cell support systems according to the present invention make it possible to construct three-dimensional cellular tissues in which all the cells can be supplied with nutrient solution and oxygen through a porous and thus microstructured surface.
The cells on the cell support systems according to the invention are supplied through a capillary system which can be formed by combining the half shells of in each case two modularly formed systems. The segments can be combined in such a way that a closed hollow article, i.e. a capillary system, is produced from the two half shells. Combination of two segments can be simplified by appropriate holding pins. The capillaries preferably have a diameter of 20-70 pm.
0.Z. 5444 - 7 -
A system of this type makes it possible to distribute released growth factors in the entire cell culture and thus make differentiation of the tissue possible. It is possible with the present invention to ensure a continuous flow out and in of nutrients, metabolic products, oxygen and growth factors to the cellular tissues.
Cell growth and cell differentiation are considerably influenced by the surface topography of the cell support. The exchange of nutrients and the distribution of the cells on the surface is determined by the nature and topography of the microstructure, i.e. in the present case by the porosity of the surface. Most applications are in this case limited by diffusion of the metabolic activity of the tissue. With the present invention, owing to the good nutrient supply, as the metabolic activity increases there is also an increase in the vascularization of the tissue, and thus a reduction in the necessary diffusion pathways.
It is an essential feature of the present invention that the cell support systems consist of formed segments which make a modular construction of an integrated system possible.
Examples of suitable materials for the cell support systems according to the invention are polycarbonate, poly(methyl methacrylate), polyurethane, polyamide,
PVC, polyethylene, polypropylene, polystyrene or polysulfonate, and blends or copolymers thereof.
Fixation of two segments to form a capillary system can take place by adhesive or microwave Or high-frequency techniques. It is self-evident that this must take place in such a way that the pores of the material are impaired only slightly, if at all.
: 0.z. 5444 - 8 -
The cell support systems, whether individual segments or preformed capillary systems, can also be connected together. This can be achieved by using spacers which are advantageously fixed to the segments during production thereof. The spacers additionally set a constant distance between individual segment layers, sO that cells are able to grow here too. The modularly formed segments preferably have spacers with a height of from 20 to 200 um. If the spacers are hollow and suitable for liquid transport, it is possible in this way to guide the nutrient solution through the entire system.
The modular design of the segments mimics the natural environment of the cells, so that proliferation, differentiation or performance of the physiological functions of the cells takes place for as long as the cells can be supplied with nutrient solution through the porous material. This supply usually takes place through from 2 to 20 cell layers, with the number of cell layers supplied depending greatly on the metabolism of the cells. Liver and kidney cells must be cultivated on cell support systems with small spacings (20-40 pm) because they require a large blood supply even in the body. On the other hand, the distance between the cell support systems can be very large, up to 200 um, for fibroblasts and cartilage cells.
The individual segments can be produced by microsystem techniques. An example of a suitable process is the
LIGA process which is a structure-forming process based on X-ray lithography, electroplating and molding. It is then possible, using the mold inserts produced by the
LIGA technique, to produce as many copies as desired by injection molding, reaction injection molding or embossing processes from various plastics with great trueness to detail and at relatively low cost. The pores can be introduced into the material by suitable projections on the mold inserts.
- 0.2. 5444 - 9 -
Fig. 2 shows by way of example the structure of a cell support according to the invention consisting of two segments. One segment consists of a central supply tube with perpendicular branches at periodically repeating intervals. These branches form a capillary system. The surface of the segments are provided with small pores which have a diameter of 0.5-5 um, depending on the cell type used. The average distance between the pores is from 1 to 10 pum, and the distance between the branches (Ll) may be between 20 and 200 um, appropriate for the cell type.
The nutrient medium is pumped actively or passively, by an appropriate gradient, through the central supply tube. The distribution of the nutrient medium and of the respiratory gases to the tissue 1s ensured by diffusion. The nutrient circulation is designed so that the medium is able to run out again through an outflow and be returned to the circulation or collected for reprocessing/disposal.
The individual segments have a modular structure so that they can be assembled with accurate fit to produce larger three-dimensional objects. This results in an artificial capillary network which makes virtually natural vascularization of the cells possible. The segments suitably have appropriate spacers as plug-in devices in order to allow two segments to be connected simply and with accurate fit.
In order to adjust the required distances between the segments according to the invention, they are provided with spacers. The spacers expediently act as plug-in device for fixing two segments (AH in Fig. 3). Flow in and out is likewise designed to allow a liquid-carrying connection between the individual segments. Spacers designed to be hollow can be employed to connect the flows in and out of segments.
: 0.Z. 5444 - 10 -
The segments can also be stacked offset relative to one another.
After the cell support has been constructed from the individual segments, the required cell types can be applied to the latter. The system is for this purpose placed in a roller bottle with a cell suspension of high density. The system remains in this bottle with a moderate speed of rotation of the roller bottle until sufficient cells have become fixed to the surface. This is typically complete after 3 to 8 hours. The system is then transferred, preferably under sterile conditions, into a Petrie dish, and fresh medium is continuously pumped through the supply connections of the segments and through the cell supports. After a few days, a multilayer cellular tissue forms on the segment surfaces and thus between the channel walls.
Alternatively, the cellular tissue can also be constructed stepwise. Firstly one plane of the cell supports according to the invention is incubated with cells. After a cell layer has grown on this lowest plane, the system is extended stepwise by one cell support layer in order to allow a cell layer to grow onto this too. The successive procedure has the advantage that a cell type can be forced to differentiate diversely through different distances between the segments or the support layers. Diverse differentiation of a «cell type is important, for example, for skin cells. Distances between segments of 3-6 cell layers have proven suitable in practice.
The cell supports according to the invention allow the cells to be supplied with nutrients satisfactorily.
This can be achieved by branching of the segments.
Fig. 4 a to e shows an example of a design of a system of this type, based on a honeycomb structure. Nutrient medium is pumped into this system through an inlet. The
- 0.2. 5444 - 11 - medium is able to run out through the outflow and be returned to the circulation or collected for reprocessing/disposal. The surface of the segments is provided with small pores of a size and distribution as described above. An artificial capillary network is also produced in this variant of the design by combination of the segments.
The diameter of the individual honeycombs (width of the opening) depends on the cell type used and may be between 70 and 180 um. In order to ensure optimal supply to the cells, the next honeycomb cell support can be stacked rotated by 90 degrees (Fig. 4 c) on top of the preceding cell support.
As described for the ladder-like structure, it is also possible with honeycombs to construct a three- dimensional cell culture. In this case too, appropriately designed plug-in connections between the honeycombs allow layer-overlapping cell growth (Fig. 4 e).
The honeycomb cell supports are, as outlined in Fig. 1, constructed from two half shells which are firmly connected together or from one half shell and one membrane.
The cell supports according to the invention can also be constructed from fairly shallow segments. Fig. 5 shows diagrammatically the construction of a cell support of this type in a pyramidal design in plan (Fig. 5 a) and side view (Fig. 5 b and c). The segments are arranged periodically in parallel rows (Fig. 5 c and d). A distance is left between the rows, preferably of half the base area of a pyramid. The individual rows of segments may in turn be connected together by, where appropriate spacers suitable for liquid transport.
Nutrient medium is pumped through the elements via an inlet. The medium can run out through an outflow and be
: 0.Z. 5444 - 12 - returned to the circulation or collected for reprocessing/disposal. The surfaces of the pyramids are provided with small pores of the size and distribution as described. The pyramids themselves are hollow and open on the base area and thus likewise form a half shell. The side view in Fig. 5 c¢ shows the connection of two segments to form a closed cell support system.
A cell culture with pyramidal cell support segments according to the invention can be constructed as follows: some pyramidal segments are placed as base element on the bottom of a suitable cell culture system. Further segments can then be positioned above these structures. The cell supports are produced by the combination of segments (see side view in Fig. 5 c).
The segments can be fitted together so that there is a space in which the cells can grow between the surfaces of the pyramids.
The advantage of this structure is that the geometric dimensions of the elements are independent of the cell type chosen. Only the distance between the layers and the pore diameter of the elements need to be adapted to the cell type used. In order to maximize the cell density and achieve a small dead volume within the pyramids, i.e. the supply elements, it is advisable for the height of the individual pyramidal elements to be small by comparison with their base area. The cell supports shown in Fig. 5 d have the following dimensions:
Height of pyramid al: 20 - 40 um
Height of base area a2: 20 - 40 pm width of segments a3: 150 - 300 pm
Length of segments ab: integral multiple of a3
Distance between cell supports a4: 50 - 300 um
As an alternative to the cell support systems constructed from two half shells, these can also be
: 0.Z. 5444 - 13 - formed by combining a half shell of a modularly formed segment with a semipermeable membrane to construct a capillary system. In this case, a permeable membrane is clamped onto the rear side of a segment. The projecting parts of the membrane can be removed by suitable etching processes. This technique has the advantage that it is unnecessary to assemble two segments with accurate fit. Semipermeable membrane such as Gorotex,
Simpatex or ceramic membranes are suitable for this purpose. Plasma etching has proved to be the preferred etching process. This is a dry etching variant used to produce structures in the pum range. After the membrane has been applied to the rear side of a segment by a phase inversion process, the projecting parts of the membrane are etched away in a plasma reactor with plasma gases such as F,, Cl, CF; /F, CCl3*/Cl and O,.
This embodiment of the present invention also eventually produces closed cavities or capillaries. The pore size and distribution of the membranes correspond to those of the segments with an average distance of from 1 to 10 um and an average diameter of from 0.5 to 5 um.
The present invention further relates to the use of the three-dimensional cell support systems for bioreactors and for cultivating eukaryotic or organic stem cells.
Important stem cells are heptocytes, kidney cells, endothelial cells, epithelial cells or myocytes.
The cell cultures used in biotechnology to produce hormones, cytokines and other pharmaceuticals which can be produced by genetic manipulation have had their genetic material modified so that they are able to produce the required substances. Since these cells have to date been cultivated almost exclusively in two- dimensional cultures, these cells differentiate very rapidly. The consequence of this is that the required substances are not produced by the cell for very long,
: 0.Z. 5444 - 14 - and the cells have to be replaced or the genetic material of the cells must be modified again. The use of the three-dimensional cell supports according to the invention for the cultivation has the advantage that the phenotype of the cells employed is substantially retained and differentiation begins later or not at all. It is possible in this way to achieve crucial production advantages.
It is thus also possible to synthesize human proteins by using cell supports according to the invention optimized for human cell types. This means that the structure and, in particular, the folding of the synthetic proteins correspond to the natural proteins in the human body.
Since the cells adhere to the cell supports according to the invention and are not present in a suspension, the proteins or other substances produced by the cells can be continuously removed through the nutrient supply circulation. With nonadherent systems, this is possible only by filtration or centrifugation of the suspensions. This makes it possible, for example to construct cell cultures as implant or even artificial hybrid organs.
The artificial production of replacement organs still encounters very great difficulties. Clinical approaches to a solution to date have been only for an artificial liver (H.G. Koebe; F.W. Schildberg in “Die kinstliche
Leber - ein Zwischenbericht.”, Wiener klinische
Wochenschrift, 110; 16; 551-563; 1998). In this case, a suspension of hepatotcytes is kept in a perfusion chamber which is connected to the patient’s blood circulation and is able to take over the function of the defective liver. This technique can to date be used only for acute liver failure because the limited survival time and the altered phenotype of the cultures precludes prolonged use thereof at present.
- 0.2. 5444 - 15 -
The use of cell support systems according to the invention has the advantage that the hepatocytes are not in suspension but are able to grow in an organotypical manner. This ensures that the heptatocytes achieve a degree of differentiation like that present in vito.
Adequate supply of the hepatocytes is possible by use of the cell support systems according to the invention and the vascularization possible in this way. The individual segments are completed in such a way that there is only one inlet and one outlet. To improve handling and to protect from infections, the system is closed by an external encapsulation. A patient’s blood circulation can then be completed via the inlet and outlet which pass to the outside. The cells in the reactor then take over the function of the liver. It is also possible with this technique to construct other artificial organs such as, for example, a kidney.
Human kidney cells can even now be maintained well in culture. Functional use of these cells for dialysis has, however, to date been frustrated by the reproduction of nephrons in conjunction with functionally differentiated kidney cells. It is possible, by combining microsystem techniques and cell culture techniques, to reproduce such functional kidney units. However, two separate circulatory systems are necessary for this, one system for the urine and one system for the blood circulation. Suitable encapsulation must also be provided in this case.
Further areas of use of the cell supports according to the invention are Langerhan’s cells of the pancreas, whose function is restricted in diabetics. Insulin can be produced artificially by putting healthy cells of this type on a framework of cell supports. The cell supports are connected to the patient’s blood
- 0.2. 5444 - 16 - circulation. The system must be closed by an external encapsulation as on use as organ replacement.
The reproduction of artificial tissue and tissue replacement on cell supports according to the invention has crucial advantages in toxicity testing.
Encapsulation is unnecessary for reproduction of the skin. To simulate the anatomical pattern it is necessary when cultivating artificial skin for the blood supply to decrease steadily toward the dermis.
Technically, this can be achieved by increasing distances between the segments in the cell culture.
Since the artificial vascularization are, owing to this manner of construction, located in accurately defined cell layers, this can also be used for penetration tests. However, for such studies, the supply of the elements in the cell culture must be stratified so that nutrient medium can be taken for analysis only in the required cell layer.
The use of cell supports according to the invention has advantages in particular in the production of models of disease. For this purpose, the cells which have the characteristic features of the disease at the cellular level are placed in a cell culture and maintained in a 3D culture by segments. This technique results in the cells remaining in the “pathological” physiological state for longer and not redifferentiating so quickly.
Such models are used mainly in the drugs industry, which 1s able to test new pharmaceuticals on such models. In addition, such models may make a crucial contribution to the understanding of some diseases.
Claims (8)
1. A cell support system of porous materials, which consists of modularly formed segments which are wholly or partly constructed from half shells.
2. A cell support system as claimed in claim 1, wherein in each case two modularly formed segments form a capillary system by combination of the half shells.
3. A cell support system as claimed in claim 1, wherein a half shell of a modularly formed segment forms a capillary system by combination with a semipermeable membrane.
4. A cell support system as claimed in any of claims 1 to 3, wherein the modularly formed segments have pores with an average diameter of from 0.5 to ] 5 pm.
5. A cell support system as claimed in any of claims 1 to 4, wherein the average distance between the pores in the modularly formed segments is from 1 to 10 um.
6. A cell support system as claimed in any of claims 1 to 5, wherein the modularly formed segments have spacers with a height of from 20 to 200 um.
7. A cell support system as claimed in claim 6, wherein the spacers are hollow and are suitable for liquid transport.
8. The use of the cell support systems as claimed in any of claims 1 to 7 for cultivating eukaryotic or organic stem cells.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1999119242 DE19919242A1 (en) | 1999-04-28 | 1999-04-28 | Modular cell support systems for three-dimensional cell growth |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200109700B true ZA200109700B (en) | 2002-06-26 |
Family
ID=7906114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200109700A ZA200109700B (en) | 1999-04-28 | 2001-11-26 | Modular cell carrier systems for the three-dimensional cell growth. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1171572A2 (en) |
| JP (1) | JP2002542817A (en) |
| CA (1) | CA2372219A1 (en) |
| DE (1) | DE19919242A1 (en) |
| WO (1) | WO2000066712A2 (en) |
| ZA (1) | ZA200109700B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8846393B2 (en) | 2005-11-29 | 2014-09-30 | Gamida-Cell Ltd. | Methods of improving stem cell homing and engraftment |
| BRPI0808051A2 (en) * | 2007-02-28 | 2014-06-24 | Cinv Ag | HIGH SURFACE GROWING SYSTEM WITH SUBSTRATE FOR SURFACE INCREASE. |
| DE102008050424B4 (en) | 2008-10-08 | 2010-11-25 | Universität Leipzig | Method and device for the homogeneous distribution of a cellular suspension in porous carrier material for the production of vital biological replacement tissue |
| PL3378930T3 (en) * | 2009-12-16 | 2020-05-18 | Vivabiocell Spa | Scaffold for the growth of tissue in vivo |
| WO2013121426A1 (en) | 2012-02-13 | 2013-08-22 | Gamida-Cell Ltd. | Culturing of mesenchymal stem cells |
| US9175266B2 (en) | 2012-07-23 | 2015-11-03 | Gamida Cell Ltd. | Enhancement of natural killer (NK) cell proliferation and activity |
| US9567569B2 (en) | 2012-07-23 | 2017-02-14 | Gamida Cell Ltd. | Methods of culturing and expanding mesenchymal stem cells |
| BR112018072586A2 (en) | 2016-05-05 | 2019-02-19 | Danisco Us Inc | protease variants and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5510254A (en) * | 1986-04-18 | 1996-04-23 | Advanced Tissue Sciences, Inc. | Three dimensional cell and tissue culture system |
| US5605835A (en) * | 1988-05-23 | 1997-02-25 | Regents Of The University Of Minnesota | Bioreactor device with application as a bioartificial liver |
| DE4206585C2 (en) * | 1992-03-03 | 1994-11-24 | Augustinus Dr Med Bader | Device for mass culture of cells |
| AU714517B2 (en) * | 1995-10-06 | 2000-01-06 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Academisch Medisch Centrum | Solid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in bio-artificial liver system |
-
1999
- 1999-04-28 DE DE1999119242 patent/DE19919242A1/en not_active Withdrawn
-
2000
- 2000-03-04 EP EP00912550A patent/EP1171572A2/en not_active Withdrawn
- 2000-03-04 JP JP2000615737A patent/JP2002542817A/en active Pending
- 2000-03-04 WO PCT/EP2000/001913 patent/WO2000066712A2/en not_active Ceased
- 2000-03-04 CA CA002372219A patent/CA2372219A1/en not_active Abandoned
-
2001
- 2001-11-26 ZA ZA200109700A patent/ZA200109700B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000066712A2 (en) | 2000-11-09 |
| WO2000066712A3 (en) | 2001-04-19 |
| CA2372219A1 (en) | 2000-11-09 |
| JP2002542817A (en) | 2002-12-17 |
| DE19919242A1 (en) | 2000-11-02 |
| EP1171572A2 (en) | 2002-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sun et al. | The bioprinting roadmap | |
| JP4389035B2 (en) | Cell culture device, bioreactor and cell culture chamber | |
| Carrier et al. | Perfusion improves tissue architecture of engineered cardiac muscle | |
| AU2012271341B2 (en) | Systems, methods, and devices relating to a biomimetic cellularized nephron unit | |
| EP2344622B1 (en) | Apparatus for culturing anchorage dependent cells | |
| AU718021B2 (en) | Diffusion gradient bioreactor and extracorporeal liver device | |
| US5792653A (en) | Substrate for cell structures | |
| AU2004299530A1 (en) | Cultured cell and method and apparatus for cell culture | |
| US20090286317A1 (en) | Modular culture system for maintenance, differentiation and proliferation of cells | |
| JP2008519598A (en) | Cell culture devices | |
| US12084642B2 (en) | Cell culture device | |
| US20160369221A1 (en) | Fluidic device and perfusion system for in vitro complex living tissue reconstruction | |
| Bettahalli et al. | Integration of hollow fiber membranes improves nutrient supply in three-dimensional tissue constructs | |
| CN1229489C (en) | Device for culturing and/or treating cells | |
| ZA200109700B (en) | Modular cell carrier systems for the three-dimensional cell growth. | |
| EP2800807B1 (en) | Bioreactor composed of watertight chamber and internal matrix for the generation of cellularized medical implants | |
| US20050015064A1 (en) | Skin cell perfusion unit | |
| US20250340808A1 (en) | Cell culture device | |
| Morelli et al. | Membrane reactors in bioartificial organs | |
| TW200306349A (en) | The cell culture method using a porous membrane | |
| Hsieh et al. | Applications of fabricated micro-and nanostructures in biomedicine | |
| De Bartolo et al. | Flat membrane bioreactor for the replacement of liver functions | |
| PL240748B1 (en) | Magnetic-hydrodynamic microfluidic platform, method of its production and method of artificial tissue culture in a magnetic micropole |